Spoken Alpha
RESMED INC
ResMed designs and manufactures cloud-connected medical devices and software for treating sleep apnea, COPD, and other chronic respiratory conditions, as well as cloud-based software solutions for residential care providers.
RESMED INC is a Healthcare company operating in Medical Instruments & Supplies with a $33.09B market cap.
RMD beat consensus EPS by 0.0% in Q2 FY2027, reported Dec 30, 2026.
23 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RMD.
$ curl https://api.spokenalpha.com/v1/companies/RMDFAQ
Spoken Alpha indexes RMD's earnings call transcripts at https://spokenalpha.com/companies/RMD. Each call links to attributed speakers and parsed analyst Q&A. RESMED INC's own investor relations page is at https://investor.resmed.com/.
RESMED INC (RMD) held its most recent earnings call on 2026-08-06, covering fiscal Q4 2026.
RESMED INC (RMD) operates in the Healthcare sector (Medical Instruments & Supplies industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 2026-12-30 | $2.95 | $2.92 | +1.1% | — | — | — | Finnhub |
| Q1 FY2027 | 2026-10-28 | — | $2.73 | — | — | — | — | EODHD |
| Q4 FY2026 | 2026-08-05 | $2.95 | $2.90 | +1.7% | $1.46B | — | — | EODHD |
| Q3 FY2026 | 2026-04-29 | $2.86 | $2.80 | +2.1% | $1.43B | — | — | EODHD |
| Q2 FY2026 | 2026-01-28 | $2.81 | $2.72 | +3.3% | $1.42B | — | — | EODHD |
| Q1 FY2026 | 2025-10-29 | $2.55 | $2.50 | +2.0% | $1.34B | — | — | EODHD |
| Q4 FY2025 | 2025-07-30 | $2.55 | $2.48 | +2.8% | $1.35B | — | — | EODHD |
| Q3 FY2025 | 2025-04-22 | $2.37 | $2.36 | +0.4% | $1.29B | — | — | EODHD |
| Q2 FY2025 | 2025-01-29 | $2.43 | $2.31 | +5.2% | $1.28B | — | — | EODHD |
| Q1 FY2025 | 2024-10-23 | $2.20 | $2.04 | +7.8% | $1.22B | — | — | EODHD |
| Q4 FY2024 | 2024-07-31 | $2.08 | $2.07 | +0.5% | $1.22B | — | — | EODHD |
| Q3 FY2024 | 2024-04-24 | $2.13 | $1.91 | +11.5% | $1.20B | — | — | EODHD |
| Q2 FY2024 | 2024-01-23 | $1.88 | $1.78 | +5.6% | $1.16B | — | — | EODHD |
| Q1 FY2024 | 2023-10-25 | $1.64 | $1.61 | +1.9% | $1.10B | — | — | EODHD |
| Q4 FY2023 | 2023-08-02 | $1.60 | $1.69 | -5.3% | $1.12B | — | — | EODHD |
| Q3 FY2023 | 2023-04-26 | $1.68 | $1.59 | +5.7% | $1.12B | — | — | EODHD |
| Q2 FY2023 | 2023-01-25 | $1.66 | $1.62 | +2.5% | $1.03B | — | — | EODHD |
| Q1 FY2023 | 2022-10-26 | $1.51 | $1.60 | -5.6% | $950.3M | — | — | EODHD |
| Q4 FY2022 | 2022-08-10 | $1.49 | $1.46 | +2.1% | $914.7M | — | — | EODHD |
| Q3 FY2022 | 2022-04-27 | $1.32 | $1.44 | -8.3% | $864.5M | — | — | EODHD |
Source: EODHD, Finnhub. RMD reported actuals as published; sparse fields render as —.